VANGUARD GROUP INC - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 47 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,598,937
+1.0%
1,698,652
+8.9%
0.00%
Q2 2023$2,573,452
+72.2%
1,559,668
+19.0%
0.00%
Q1 2023$1,494,068
+33.1%
1,310,586
+5.3%
0.00%
Q4 2022$1,122,873
-18.8%
1,244,732
+5.3%
0.00%
Q3 2022$1,382,000
+68.5%
1,181,540
-7.9%
0.00%
Q2 2022$820,000
-75.5%
1,282,5060.0%0.00%
Q1 2022$3,347,000
-30.7%
1,282,506
+3.2%
0.00%
Q4 2021$4,832,000
+5.1%
1,242,189
+17.8%
0.00%
Q3 2021$4,597,000
+10.7%
1,054,304
+0.8%
0.00%
Q2 2021$4,153,000
-6.7%
1,046,078
+22.1%
0.00%
Q1 2021$4,453,000
-6.9%
856,426
-4.2%
0.00%
Q4 2020$4,785,000
+14.5%
894,395
+3.9%
0.00%
Q3 2020$4,179,000
+16.2%
860,910
+16.4%
0.00%
Q2 2020$3,595,000
+161.8%
739,772
+18.0%
0.00%
Q1 2020$1,373,000
-60.2%
626,808
+5.8%
0.00%
Q4 2019$3,448,000
+287.9%
592,408
+112.0%
0.00%
Q3 2019$889,000
-32.2%
279,412
-10.5%
0.00%
Q2 2019$1,311,000
-51.8%
312,131
-20.7%
0.00%
Q1 2019$2,720,000
+27.2%
393,644
+16.0%
0.00%
Q4 2018$2,139,000
-73.4%
339,448
-26.2%
0.00%
Q3 2018$8,055,000460,0320.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$16,188,081100.00%
Vahanian & Associates Financial Planning Inc. 725,208$1,196,5933.78%
Bracebridge Capital, LLC 428,571$707,1420.39%
Latash Investments, LLC 243,134$401,1710.32%
XTX Topco Ltd 138,145$227,9390.04%
ARMISTICE CAPITAL, LLC 1,158,000$1,910,7000.03%
OCCUDO QUANTITATIVE STRATEGIES LP 84,355$139,1860.01%
Hillsdale Investment Management Inc. 66,600$109,8900.01%
D.B. Root & Company, LLC 12,950$21,3680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 147,856$243,9620.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders